本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Applied Therapeutics Inc.

0.3798
+0.161573.98%
成交量:1.86亿
成交额:5,855.51万
市值:5,480.54万
市盈率:-0.80
高:0.3800
开:0.2517
低:0.2211
收:0.2183
52周最高:10.48
52周最低:0.2182
股本:1.44亿
流通股本:1.20亿
量比:16.97
换手率:154.34%
股息:- -
股息率:- -
每股收益(TTM):-0.4752
每股收益(LYR):-0.7570
净资产收益率:-150.82%
总资产收益率:-84.32%
市净率:3.14
市盈率(LYR):-0.50

数据加载中...

2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/06

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/06

重要事件披露

Form 8-K - Current report
2024/03/05

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/22

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/26

SEC问询函

Form CORRESP - Correspondence
2024/01/04

重要事件披露

Form 8-K - Current report
2024/01/03

重要事件披露

Form 8-K - Current report
2023/12/30

重要事件披露

Form 8-K - Current report
2023/12/22

SEC问询函

Form CORRESP - Correspondence